Home › Funds › ANCHOR CAPITAL ADVISORS LLC › GMED
ANCHOR CAPITAL ADVISORS LLC position in GMED
GLOBUS MED INC · Health Care
ANCHOR CAPITAL ADVISORS LLC reported holding 629,155 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$47.1M, representing 1.47% of its reported portfolio and ranking #15 among its reported holdings. ANCHOR CAPITAL ADVISORS LLC has disclosed GMED holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ANCHOR CAPITAL ADVISORS LLC's GMED position evolved
ANCHOR CAPITAL ADVISORS LLC first disclosed a stake in GMED in Q1 2024 at 417,052 shares (US$22.4M). The position peaked in Q4 2025 at 695,352 shares, worth US$60.7M. Across 11 filings, ANCHOR CAPITAL ADVISORS LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 629,155 shares valued at US$47.1M — a reduction of -19,183 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2025 (shares rose 52% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 417.05K | $22.37M | New |
| Q2 2024 | 409.98K | $28.08M | Reduce |
| Q3 2024 | 508.36K | $36.37M | Add |
| Q4 2024 | 482.42K | $39.90M | Reduce |
| Q1 2025 | 536.98K | $39.31M | Add |
| Q2 2025 | 562.95K | $33.23M | Add |
| Q3 2025 | 800.28K | $45.83M | Add |
| Q4 2025 | 695.35K | $60.71M | Reduce |
| Q1 2026 | 639.52K | $55.10M | Reduce |
| Q2 2026 | 648.34K | $51.23M | Add |
| Q3 2026 | 629.15K | $47.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
More on ANCHOR CAPITAL ADVISORS LLC
FAQ
How long has ANCHOR CAPITAL ADVISORS LLC held GMED?
ANCHOR CAPITAL ADVISORS LLC has disclosed GMED holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is ANCHOR CAPITAL ADVISORS LLC's current position in GMED?
As of Q3 2026, ANCHOR CAPITAL ADVISORS LLC holds 629.15K shares of GMED (GLOBUS MED INC), valued at $47.12M, representing 1.47% of its reported portfolio and ranking #15.
Has ANCHOR CAPITAL ADVISORS LLC been buying or selling GMED?
In the latest 13F filing (Q3 2026), ANCHOR CAPITAL ADVISORS LLC reduced its position in GMED. The position peaked in Q4 2025 at 695.35K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.